Patient Safety Collaboratives (PSCs) have engaged nearly 11,000 care homes over the last two years, in an NHS England commissioned programme designed to help support care homes in managing deterioration. Their role is to support care homes in adopting tools that help staff to identify the early signs of physical deterioration in residents. Over 7,000 [...]
To mark ADHD Awareness Month new figures are being shared showing almost 75,000 people (aged 6-18 years) have received an objective assessment for ADHD over the last five years since Academic Health Science Networks began to support a new digital innovation, QbTest. The innovation has improved patient experience and patients require fewer appointments before being [...]
In this blog, East Midlands AHSN (EMAHSN) Managing Director Nicole McGlennon discusses the considerations of embedding change, how can healthcare systems create the conditions for healthcare innovation adoption and identifies five key areas NHS systems can consider. In recognition of October also being ADHD awareness month, Nicole refers to our Focus ADHD project and how [...]
A new AHSN Network programme which aims to improve lower limb wound care for patients has announced its first pilot sites. The AHSN Network’s Transforming Wound Care new national spread and adoption programme aims to ensure all patients with lower limb wounds receive evidence-based care which leads to: faster healing of wounds improved quality of [...]
We’re pleased to be exhibiting at the Health Excellence Through Technology (HETT) show on 27 and 28 September 2022, at the ExCeL London. Come and see us at our exhibition stand (number E58) where you can speak to AHSN colleagues and partners; find out more about the AHSNs and how to access support; and meet [...]
Almost 57,000 people (aged 6-18 years) have received an objective assessment for ADHD since the AHSNs began to support a new digital innovation, QbTest. The innovation, which speeds up the time to diagnosis, has improved patient experience and saved the NHS a potential £19.5m since 2017*. It is being used in 59 trusts across 113 [...]
The AHSN Network is helping to transform Attention Deficit Hyperactivity Disorder (ADHD) services across England with the rollout of technology that can provide an objective assessment and help families to receive a diagnosis more quickly. New figures released during ADHD Awareness Month (October) show that, since the start of the first ‘demonstrator’ site in the [...]
Since March 2020, Academic Health Science Networks have supported the rollout of an evidence-based Attention Deficit Hyperactivity Disorder (ADHD) programme called Focus ADHD. Working closely with mental health trusts and community paediatric services, the programme seeks to improve the ADHD assessment offer for children and young people. In the first year of the national programme, [...]
Meet Tony Doyle, Managing Director of Qbtech, whose company’s mission it is to transform the lives of people with attention deficit hyperactivity disorder (ADHD) through objective data to help streamline the diagnosis process and help support children and families. Tony tells us why it’s so important that people receive early diagnosis of the condition, and [...]
Thousands of toddlers will be screened for an inherited gene that can cause early heart disease as part of a new national pilot programme delivered by the AHSN Network. Over the next two years, 30,000 children across England will be assessed using a heel prick blood test to identify if they have a ‘faulty gene’ [...]
Meet Jane Van Aken, Director of Product Development at Spirit Digital, a remote monitoring solution supported by the AHSN Network. Jane discusses her ‘light bulb’ moment, advice for budding innovators and how virtual monitoring has been a lifeline for many during the coronavirus (COVID-19) pandemic. Tell us about your innovation – what and why? CliniTouch [...]
We are working with mental health trusts and community paediatric services across England to improve the assessment process for Attention Deficit Hyperactivity Disorder (ADHD) for children and young people through our Focus ADHD national programme. ADHD is a neurodevelopmental disorder and affects around 5% of school-aged children worldwide [1]. Symptoms include inattentiveness, hyperactivity and impulsiveness. If [...]
